Background The purpose of this study was to investigate an association between EGFR
mutation status and 18F‐fluorodeoxyglucose positron emission tomography‐computed …

Background A non-invasive, simple, and convenient method to evaluate the presence of
epidermal growth factor receptor (EGFR) mutations is important for initial treatment decisions …

Purpose The identification of the mutation status of the epidermal growth factor receptor
(EGFR) is important for the optimization of treatment in patients with pulmonary …

Purpose. To compare 18F‐fluorodeoxyglucose positron emission tomography (FDG‐PET)
and computed tomography (CT) imaging characteristics in non‐small cell lung cancer …

Objective Epidermal growth factor receptor (EGFR) mutations in lung adenocarcinoma are
involved in the tumorigenesis and regulation of cell metabolism via Akt signaling. F-18 …

Background To investigate whether radiomic features from (18 F)-fluorodeoxyglucose
positron emission tomography/computed tomography [(18 F)-FDG PET/CT] can predict …

AIM: The aim of this study is to evaluate the diagnostic value of PET-CT scan for the
prediction of EGFR mutation status and the contribution of TTF-1 expression to PET-CT …

Purpose This study aimed to investigate the value of metabolic and heterogeneity
parameters of 2-deoxy-2 [18F] fluoro-D-glucose ([18F] FDG) positron emission …

Objective The aim of this study was to investigate whether quantitative and qualitative
features extracted from PET/computed tomography (CT) can be used as imaging biomarkers …

Comprehensively investigate the association of CT morphology and clinical findings of
adenocarcinoma with EGFR mutation status. Retrospectively included 282 patients who was …